<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20110726007128N11</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2025-09-26</date_registration>
      <primary_sponsor>Tabriz University of Medical Sciences</primary_sponsor>
      <public_title>Enhancing Dental Implants with Your Own Tooth or Bone: A Scientific Comparison</public_title>
      <acronym></acronym>
      <scientific_title>The comparison between autogenous tooth and autogenous bone graft for phenotype modification around immediate implants</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2025-09-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>38</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/86072</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: In this study, participants will be allocated in a 1:1 ratio using block randomization with a block size of 4 to assign them to either the intervention or control group.
Randomization will be performed at the individual level.
The random sequence will be generated using statistical software (SPSS Random Number Generator or Random Allocation Software).
To ensure allocation concealment, sequentially numbered, opaque, sealed envelopes (SNOSE) will be used. These envelopes will be prepared and safeguarded by an independent colleague not involved in the research team. After obtaining informed consent and confirming eligibility criteria, the envelope corresponding to the patient's inclusion order will be opened to reveal the assigned intervention type, Blinding description: Outcome Assessors
a) Clinical Photograph Assessor (for Pink Esthetic Score - PES):
Status: Blinded.
Procedure: Standardized clinical photographs of the implant site will be taken at the 6-month follow-up. All photographs will be coded with a unique patient ID number that does not indicate the group allocation. A single, calibrated assessor, who is independent of the surgical team and has not been involved in the patient's care, will score all photographs using the PES index. This assessor will be explicitly blinded to the patient's group assignment.

b) Radiographic Assessor (for Buccal Bone Thickness):
Status: Blinded.
Procedure: All Cone-Beam Computed Tomography (CBCT) scans taken pre-operatively and at 6 months will be analyzed using dedicated software. The scans will be de-identified and assigned random codes. A radiologist or a trained assessor, who is independent of the study and blinded to the group allocation and the time point (pre-op vs. 6-month), will measure the buccal bone thickness. The software screen will be set up to display only the coded image, hiding any patient or group identifiers.

Data analyzer: 
Status: Blinded.
Procedure: For the primary statistical analysis, the data file provided to the statistician will contain generic group labels (e.g., "Group A" and "Group B"). The identity of which group is the intervention (dentin graft) and which is the control (bone graft) will be concealed until after the analysis of all primary and secondary outcomes is complete and the results are finalized.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Periodontal disease.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: After tooth extraction and site preparation, the implant is placed immediately in the anterior maxilla. The gap between the implant and the buccal socket wall is filled with a demineralized autogenous dentin graft prepared from the patient’s extracted tooth. A 1.5 millimeter thick subepithelial connective tissue graft is then harvested from the patient’s palate and placed over the implant and dentin graft, then sutured. All procedures are performed under local anesthesia.  Preparation of the autogenous dentin graft: The extracted teeth are cleaned with ethyl alcohol, the root portions are collected and ground. The ground particles are placed in distilled water and hydrogen peroxide solution, then dehydrated in ethyl alcohol and ethyl ether, and finally partially demineralized in 2% nitric acid (HNO₃). Intervention 2: Control group: After tooth extraction and site preparation, the implant is placed immediately in the anterior maxilla. The gap between the implant and the buccal socket wall is filled with autogenous bone graft. A 1.5 millimeter thick subepithelial connective tissue graft is then harvested from the patient’s palate and placed over the implant and bone graft, then sutured. All procedures are performed under local anesthesia.The autogenous bone graft is harvested from the adjacent site of the surgical area using a bone scraper and shaped to fill the gap between the implant and the buccal socket wall.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no further information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr Adileh Shirmohamadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Daneshgah street, Golgasht, Tabriz University of Medical Science</address>
        <city>Tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5166614711</zip>
        <telephone>+98 41 1335 5966</telephone>
        <email>shirmohamadia@tbzmed.ac.ir</email>
        <affiliation>Tabriz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr Adileh Shirmohamadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Daneshgah street, Golgasht, Tabriz University of Medical Science</address>
        <city>Tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5166614711</zip>
        <telephone>+98 41 1335 5966</telephone>
        <email>shirmohamadia@tbzmed.ac.ir</email>
        <affiliation>Tabriz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Adults aged ≥ 18 years
Systemic condition suitable for oral surgery (ASA I or II)
Healthy periodontium in adjacent teeth (no probing depth ≥ 4 mm and no bleeding on probing)
indication for immediate implant placement in the anterior region for endodontic or restorative reasons
Ability and willingness to attend follow-up visits and provide informed consent</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Poor oral hygiene (high Plaque Index or inability to maintain oral hygiene)
Active smoking (&gt;10 cigarettes/day or ≥10 pack-years)
Pregnancy or breastfeeding
Severe periodontal disease
Uncontrolled diabetes (HbA1c &gt; 7.0%)
History of head and neck radiotherapy
Current or past use of bisphosphonates, denosumab, or long-term systemic corticosteroids/immunosuppressants
alcohol or substance abuse
Systemic or metabolic bone diseases interfering with healing
Inadequate bone anatomy to achieve primary implant stability
inability or unwillingness to attend follow-up visits
Active infection at the extraction site (clinical signs of infection or purulence)</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>K05.6</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Periodontal disease, unspecified</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Surgery</i_code>
      <i_code>Treatment - Surgery</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: After tooth extraction and site preparation, the implant is placed immediately in the anterior maxilla. The gap between the implant and the buccal socket wall is filled with a demineralized autogenous dentin graft prepared from the patient’s extracted tooth. A 1.5 millimeter thick subepithelial connective tissue graft is then harvested from the patient’s palate and placed over the implant and dentin graft, then sutured. All procedures are performed under local anesthesia.  Preparation of the autogenous dentin graft: The extracted teeth are cleaned with ethyl alcohol, the root portions are collected and ground. The ground particles are placed in distilled water and hydrogen peroxide solution, then dehydrated in ethyl alcohol and ethyl ether, and finally partially demineralized in 2% nitric acid (HNO₃).</i_keyword>
      <i_keyword>Control group: After tooth extraction and site preparation, the implant is placed immediately in the anterior maxilla. The gap between the implant and the buccal socket wall is filled with autogenous bone graft. A 1.5 millimeter thick subepithelial connective tissue graft is then harvested from the patient’s palate and placed over the implant and bone graft, then sutured. All procedures are performed under local anesthesia.The autogenous bone graft is harvested from the adjacent site of the surgical area using a bone scraper and shaped to fill the gap between the implant and the buccal socket wall</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Buccal bone thickness. Timepoint: Measuring buccal bone thickness at the beginning of the study (before the intervention) and 6 months after surgery. Method of measurement: Measured using cone-beam computed tomography.</prim_outcome>
      <prim_outcome>Soft tissue thickness. Timepoint: Baseline (at implant placement)and 6 months after surgery. Method of measurement: Measured using a size 20 endodontic file with a silicone stop at 1 mm and 3 mm from the line connecting the marginal points of adjacent teeth.</prim_outcome>
      <prim_outcome>Pink Esthetic Score. Timepoint: 6 months after surgery, after placement of the implant prosthesis. Method of measurement: Assessed visually and scored according to the standard Pink Esthetic Score index.</prim_outcome>
      <prim_outcome>Implant survival. Timepoint: 6 months after surgery. Method of measurement: Evaluated clinically by recording implant mobility, infection, or loss.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tabriz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2025-01-27</approval_date>
        <contact_name>Ethics Committee of Tabriz University of Medical Sciences</contact_name>
        <contact_address>Faculty of Dentistry, Tabriz University of Medical Sciences, Golgasht Ave, Tabriz, Iran Tabriz East Azarbaijan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
